KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Return on Equity (2016 - 2025)

Emergent BioSolutions (EBS) has 15 years of Return on Equity data on record, last reported at 0.14% in Q3 2025.

  • For Q3 2025, Return on Equity rose 60.0% year-over-year to 0.14%; the TTM value through Sep 2025 reached 0.14%, up 60.0%, while the annual FY2024 figure was 0.34%, 41.0% up from the prior year.
  • Return on Equity reached 0.14% in Q3 2025 per EBS's latest filing, down from 0.26% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.26% in Q1 2021 and bottomed at 1.12% in Q2 2024.
  • Average Return on Equity over 5 years is 0.17%, with a median of 0.02% recorded in 2022.
  • Peak YoY movement for Return on Equity: tumbled -62bps in 2023, then surged 137bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.14% in 2021, then crashed by -212bps to 0.16% in 2022, then plummeted by -259bps to 0.56% in 2023, then surged by 32bps to 0.38% in 2024, then surged by 135bps to 0.14% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.14% in Q3 2025, 0.26% in Q2 2025, and 0.25% in Q1 2025.